SCHEMBL9624196

SCHEMBL9624196

C=CCC1=CC(=O)C=C(CC=C)C1=O

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 2/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ TOP2A P11388 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2049867 0.80 HKDC1 (0.55) ALOX5
SCHEMBL5141296 0.76 MAOA (0.44) —
SCHEMBL3807551 0.74 STAT3 (0.33) TOP2A
SCHEMBL10929858 0.73 — —
SCHEMBL11238835 0.72 — —
SCHEMBL1140705 0.69 MEN1 (0.47) —
SCHEMBL4590024 0.68 — —
Phosphine SCHEMBL14764881 0.68 MEN1 (0.46) —
SCHEMBL10747842 0.67 — —
SCHEMBL11497676 0.66 TOP2A (0.31) TOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11932592-B2 Process for the transformation of primary aliphatic alcohols into higher aliphatic alcohols Alma Mater Studiorum—Universita' di Bologna (IT) 2024-03-19 — — US disclosed
EP-3774706-B1 IMPROVED PROCESS FOR THE TRANSFORMATION OF PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS UNIV BOLOGNA ALMA MATER STUDIORUM (IT) 2023-12-20 — — EP disclosed
US-20210163385-A1 PROCESS FOR THE TRANSFORMATION OF PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2021-06-03 — — US disclosed
US-10580953-B2 Thermoelectric conversion element, thermoelectric conversion module, method for manufacturing thermoelectric conversion element, and method for manufacturing thermoelectric conversion module FUJIFILM CORPORATION (JP) 2020-03-03 — — US disclosed
US-20170179361-A1 THERMOELECTRIC CONVERSION ELEMENT, THERMOELECTRIC CONVERSION MODULE, METHOD FOR MANUFACTURING THERMOELECTRIC CONVERSION ELEMENT, AND METHOD FOR MANUFACTURING THERMOELECTRIC CONVERSION MODULE FUJIFILM CORPORATION (JP) 2017-06-22 — — US disclosed
US-5118823-A Oxidation of dihydroxyaromatic compounds to quinones EASTMAN KODAK COMPANY (US) 1992-06-02 — — US disclosed
US-3987068-A COPPER-NITRILE COMPLEX CATALYST E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11932592-B2 Process for the transformation of primary aliphatic alcohols into higher aliphatic alcohols ADH1A, ADH5, ADH1C PTGS1 1599/4885ALOX5 432/4885TOP2A 493/4885
US-20210163385-A1 PROCESS FOR THE TRANSFORMATION OF PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS ADH1A, ADH5, ADH1C PTGS1 1599/4885ALOX5 432/4885TOP2A 493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback